Comparison of Aspiration Catheters with Modified Standard Catheters for Treatment of Large Pulmonary Embolism Using an In-vitro Patho-Physiological Model.
Aspiration
Comparative in-vitro study
Fragmentation
Interventional radiology
Mechanical thrombectomy
Patho-physiological model
Pulmonary embolism
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
27
04
2021
accepted:
06
10
2021
pubmed:
20
11
2021
medline:
1
1
2022
entrez:
19
11
2021
Statut:
ppublish
Résumé
The presented in-vitro study provides a comparison of various catheters for mechanical treatment of large-burden pulmonary embolism (PE) under standardized conditions, using a new test rig. Dedicated aspiration catheters (JETi®, Penumbra Indigo®, Aspirex®) were compared with standard catheters (Pigtail, Multi-Purpose, Balloon Catheter) applied for embolus fragmentation. Emboli prepared from porcine blood were washed into the test rig which consists of anatomical models of the pulmonary artery (PA) and of the right heart in combination with a pulsatile drive system. For all catheters, the duration of the recanalization procedure and the weight percentage (wt%) of the remaining, removed and washed-down clot fractions were evaluated. For aspiration catheters, the aspirated volume was measured. All catheters achieved full or partial recanalization. The aspiration catheters showed a significantly (p < 0.05) lower procedure time (3:15 min ± 4:26 min) than the standard fragmentation catheters (7:19 min ± 4:40 min). The amount of thrombus removed by aspiration was significantly (p < 0.001) higher than that by fragmentation, averaging 86.1 wt% ± 15.6 wt% and 31.7 wt% ± 3.8 wt%, respectively. Nonetheless, most of the residue was fragmented into pieces of ≥ 1 mm and washed down. Only in 2 of 36 tests, a residual thrombus of 11.9 wt% ± 5.1 wt% remained in the central PA. Comparison under standardized in-vitro patho-physiological conditions showed that embolus fragmentation with standard catheters is clearly inferior to aspiration with dedicated catheters in the treatment of large-burden PE, but can still achieve considerable success. No level of evidence, experimental study.
Identifiants
pubmed: 34796375
doi: 10.1007/s00270-021-02987-y
pii: 10.1007/s00270-021-02987-y
pmc: PMC8601750
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-120Informations de copyright
© 2021. The Author(s).
Références
Heart Lung Circ. 2015 Jan;24(1):46-54
pubmed: 25060976
Lancet Respir Med. 2020 Mar;8(3):277-287
pubmed: 31615719
Curr Treat Options Cardiovasc Med. 2021;23(7):44
pubmed: 33994774
J Vasc Interv Radiol. 2009 Nov;20(11):1431-40
pubmed: 19875060
J Vasc Interv Radiol. 2001 Oct;12(10):1185-91
pubmed: 11585885
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
Invest Radiol. 2001 Jun;36(6):317-22
pubmed: 11410751
Lancet Respir Med. 2020 Mar;8(3):222-224
pubmed: 31629671
Radiology. 1995 Oct;197(1):157-62
pubmed: 7568815
JACC Cardiovasc Interv. 2021 Feb 8;14(3):319-329
pubmed: 33454291
J Vasc Interv Radiol. 2002 Aug;13(8):831-9
pubmed: 12171987
Int J Cardiol. 2020 Aug 15;313:129-131
pubmed: 32471650
J Vasc Surg. 2015 Feb;61(2):559-65
pubmed: 25524824
J Vasc Interv Radiol. 2009 May;20(5):634-9
pubmed: 19324573
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
Cardiovasc Intervent Radiol. 2001 Sep-Oct;24(5):319-23
pubmed: 11815837
Cardiovasc Intervent Radiol. 1998 May-Jun;21(3):199-204
pubmed: 9626434
JACC Cardiovasc Interv. 2019 May 13;12(9):859-869
pubmed: 31072507
J Vasc Interv Radiol. 2012 Feb;23(2):167-79.e4; quiz 179
pubmed: 22192633
J Thromb Thrombolysis. 2020 Jul;50(1):239-241
pubmed: 32394237
Eur Radiol. 2001;11(10):2047-9
pubmed: 11702140
World J Radiol. 2017 Dec 28;9(12):426-437
pubmed: 29354208
Chest. 2007 Aug;132(2):657-63
pubmed: 17699137
J Am Coll Cardiol. 2000 Aug;36(2):375-80
pubmed: 10933345
J Thorac Cardiovasc Surg. 1988 Dec;96(6):952-61
pubmed: 3193804
Lancet. 1991 Nov 9;338(8776):1186-9
pubmed: 1682601